Ceryvyn Therapeutics Ltd
OPT
Classifica tra le azioni
#31797
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Prezzo delle azioni
$0.00846342
Ultima sincronizzazione: 2026-07-27
Capitalizzazione di mercato
$11.27M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-99.75%
Paese
AU
Scambia Ceryvyn Therapeutics Ltd (OPT)
Categoria
Healthcare
Storico del prezzo dell'azione per Ceryvyn Therapeutics Ltd (OPT)
Prezzo di chiusura più alto: $3.41 il 2025-04-01
Prezzo di chiusura più basso: $13.17 il 2020-10-01
Prezzo di chiusura più basso: $13.17 il 2020-10-01
Storico del prezzo dell'azione di Ceryvyn Therapeutics Ltd dal 2020 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2025 | -4.06% |
| 2024 | 37.44% |
| 2023 | -49.05% |
| 2022 | -27.97% |
| 2021 | -41.46% |
| 2020 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $518.37 | 21.61% |
US
|
|
| $248.67 | 804.59% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $885.59 | 6.09% |
NL
|
|
| $752.87 | 7.40% |
CH
|
